Telomerase (hTERT 611–626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells
To access this article, please choose from the options below
PII: S0301-472X(06)00658-8
doi:10.1016/j.exphem.2006.10.006
© 2007 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.
